Literature DB >> 9620327

Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans.

E Mandishona1, A P MacPhail, V R Gordeuk, M A Kedda, A C Paterson, T A Rouault, M C Kew.   

Abstract

Although the iron-loading disease, hereditary hemochromatosis, has a strong causal association with hepatocellular carcinoma (HCC), the carcinogenic potential of dietary iron overload in Black Africans is not known. We investigated this potential by evaluating iron status, alcohol consumption, markers for hepatitis B (HBV) and C virus (HCV) infections, and exposure to dietary aflatoxin B1 in 24 rural patients with this tumor, 48 race-, sex-, and age-matched hospital-based controls, and 75 related or unrelated close family members of the cancer patients. Iron overload was defined as a raised serum ferritin concentration in combination with a transferrin saturation > or = 60%, and was confirmed histologically when possible. Among 24 patients and 48 hospital controls, the risk of developing HCC in the iron-loaded subjects was 10.6 (95% confidence limits of 1.5 and 76.8) relative to individuals with normal iron status, after adjusting for alcohol consumption, chronic HBV and HBC infections, and exposure to aflatoxin B1. The risk of HCC in subjects with HBV infection was 33.2 (7.2, 153.4) (odds ratio [95% confidence limits]), HCV infection 6.4 (0.3, 133.5), and alcohol consumption 2.0 (0.5, 8.2). Aflatoxin B1 exposure did not appear to increase the risk of HCC. The population attributable risk of iron overload in the development of HCC was estimated to be 29%. Among 20 cancer patients and 75 family members, the risk of developing HCC with iron overload was 4.1 (0.5, 32.2). We conclude that dietary iron overload may contribute to the development of HCC in Black Africans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620327     DOI: 10.1002/hep.510270614

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

1.  Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort.

Authors:  Neal D Freedman; Amanda J Cross; Katherine A McGlynn; Christian C Abnet; Yikyung Park; Albert R Hollenbeck; Arthur Schatzkin; James E Everhart; Rashmi Sinha
Journal:  J Natl Cancer Inst       Date:  2010-08-20       Impact factor: 13.506

2.  Prevention of hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 3.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 4.  A Review on Dietary and Non-Dietary Risk Factors Associated with Gastrointestinal Cancer.

Authors:  Lohith Mysuru Shivanna; Asna Urooj
Journal:  J Gastrointest Cancer       Date:  2016-09

Review 5.  Problem of hepatocellular carcinoma in West Africa.

Authors:  Nimzing G Ladep; Olufunmilayo A Lesi; Pantong Mark; Maud Lemoine; Charles Onyekwere; Mary Afihene; Mary Me Crossey; Simon D Taylor-Robinson
Journal:  World J Hepatol       Date:  2014-11-27

Review 6.  Non-viral causes of hepatocellular carcinoma.

Authors:  Wojciech Blonski; David S Kotlyar; Kimberly A Forde
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

7.  Non-viral factors contributing to hepatocellular carcinoma.

Authors:  Manal A Hamed; Sanaa A Ali
Journal:  World J Hepatol       Date:  2013-06-27

8.  Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins.

Authors:  J B Whitfield; L M Cullen; E C Jazwinska; L W Powell; A C Heath; G Zhu; D L Duffy; N G Martin
Journal:  Am J Hum Genet       Date:  2000-03-15       Impact factor: 11.025

Review 9.  Hepatic iron overload and hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

Review 10.  Nutrition and metabolism in hepatocellular carcinoma.

Authors:  Robert J Smith
Journal:  Hepatobiliary Surg Nutr       Date:  2013-04       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.